articaine hcl 4 % and epinephrine 1 : 100000
henry schein shvadent (2009 ) ltd - articaine hydrochloride; epinephrine bitartrate - solution for injection - epinephrine bitartrate 0.031 mg / 1.7 ml; articaine hydrochloride 68 mg / 1.7 ml - articaine - for infiltration anaesthesia and nerve block anaesthesia in clinical dentistry.
articaine hcl 4 % and epinephrine 1 : 200000
henry schein shvadent (2009 ) ltd - articaine hydrochloride; epinephrine bitartrate - solution for injection - epinephrine bitartrate 0.015 mg / 1.7 ml; articaine hydrochloride 68 mg / 1.7 ml - articaine - for infiltration anaesthesia and nerve block anaesthesia in clinical dentistry.
septanest 1:200,000 articaine hcl 4% with adrenaline 1:200,000, solution for injection 2.2 ml cartridge
specialites septodont pty ltd - articaine hydrochloride, quantity: 88 mg; adrenaline (epinephrine) acid tartrate, quantity: 0.02 mg (equivalent: adrenaline (epinephrine), qty 0.011 mg) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; water for injections - ? septanest 1:200,000 is indicated for local anaesthesia for simple dental procedures in adults, adolescents and children 4 years of age and older. ? septanest 1:200,000 is indicated only for dental procedures
septanest 1:200,000 articaine hcl 4% with adrenaline 1:200,000, solution for injection 1.7 ml cartridge
specialites septodont pty ltd - articaine hydrochloride, quantity: 68 mg; adrenaline (epinephrine) acid tartrate, quantity: 0.0155 mg (equivalent: adrenaline (epinephrine), qty 0.0085 mg) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; water for injections - ? septanest 1:200,000 is indicated for local anaesthesia for simple dental procedures in adults, adolescents and children 4 years of age and older. ? septanest 1:200,000 is indicated only for dental procedures
septanest 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 2.2ml solution for injection
specialites septodont pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty microgram/ml); articaine hydrochloride, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; sodium chloride - for local or regional anaesthesia for both simple and complex dental procedures in adult, adolescents and children 4 years of age and older. septanest 1:100,000 is indicated only for dental procedures.
septanest 1:100,000 articaine hydrochloride and adrenaline (epinephrine) 1.7ml solution for injection
specialites septodont pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml); articaine hydrochloride, quantity: 40 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; sodium hydroxide; water for injections - for local or regional anaesthesia for both simple and complex dental procedures in adult, adolescents and children 4 years of age and older. septanest 1:100,000 is indicated only for dental procedures.
vigamox
novartis israel ltd - moxifloxacin as hydrochloride - ophthalmic solution - moxifloxacin as hydrochloride 0.5 % - moxifloxacin - moxifloxacin - for the treatment of bacterial conjunctivitis caused by susceptible strains or organisms.
esbriet 267 mg
roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.
esbriet 267 mg
roche pharmaceuticals (israel) ltd - pirfenidone - hard capsule - pirfenidone 267 mg - pirfenidone - esbriet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).27/01/2019 בקשה לתוספת התויה renal impairment no dose adjustment is necessary in patients with mild to moderate renal impairment. esbriet should be used with caution in patients with moderate (crcl 30-50 ml/min) renal impairment.
mabthera 1400 mg s.c.
roche pharmaceuticals (israel) ltd - rituximab - solution for injection - rituximab 1400 mg / 11.7 ml - rituximab - mabthera subcutaneous formulation is indicated in adults for non-hodgkin`s lymphoma (nhl):• mabthera is indicated for the treatment of previously untreated patients with stage iii-iv follicular lymphoma in combination with chemotherapy.• mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy.• mabthera is indicated for the treatment of patients with cd20 positive diffuse large b cell non-hodgkin’s lymphoma in combination with chop (cyclophosphamide, doxorubicin, vincristine, prednisolone) chemotherapy.